264 related articles for article (PubMed ID: 17143052)
1. Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia.
Clarke R; Lewington S; Sherliker P; Armitage J
Curr Opin Clin Nutr Metab Care; 2007 Jan; 10(1):32-9. PubMed ID: 17143052
[TBL] [Abstract][Full Text] [Related]
2. The worldwide challenge of the dementias: a role for B vitamins and homocysteine?
Smith AD
Food Nutr Bull; 2008 Jun; 29(2 Suppl):S143-72. PubMed ID: 18709889
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine-lowering trials for prevention of cardiovascular events: a review of the design and power of the large randomized trials.
B-Vitamin Treatment Trialists' Collaboration
Am Heart J; 2006 Feb; 151(2):282-7. PubMed ID: 16442889
[TBL] [Abstract][Full Text] [Related]
4. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements.
Clarke R; Armitage J
Semin Thromb Hemost; 2000; 26(3):341-8. PubMed ID: 11011852
[TBL] [Abstract][Full Text] [Related]
5. Effect of multivitamin supplementation on the homocysteine and methylmalonic acid blood concentrations in women over the age of 60 years.
Wolters M; Hermann S; Hahn A
Eur J Nutr; 2005 Mar; 44(3):183-92. PubMed ID: 15309436
[TBL] [Abstract][Full Text] [Related]
6. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial.
Ebbing M; Bleie Ø; Ueland PM; Nordrehaug JE; Nilsen DW; Vollset SE; Refsum H; Pedersen EK; Nygård O
JAMA; 2008 Aug; 300(7):795-804. PubMed ID: 18714059
[TBL] [Abstract][Full Text] [Related]
7. [Meta-analysis on effect of combined supplementation of folic acid, vitamin B12 and B6 on risk of cardio-cerebrovascular diseases in randomized control trials].
Lan X; Dang SN; Zhao YL; Yan H; Yan H
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):1028-34. PubMed ID: 27453118
[TBL] [Abstract][Full Text] [Related]
8. Homocysteine, B-vitamins and CVD.
McNulty H; Pentieva K; Hoey L; Ward M
Proc Nutr Soc; 2008 May; 67(2):232-7. PubMed ID: 18412997
[TBL] [Abstract][Full Text] [Related]
9. Homocysteine, folic acid, B vitamins and cardiovascular risk.
Blacher J; Safar ME
J Nutr Health Aging; 2001; 5(3):196-9. PubMed ID: 11458292
[TBL] [Abstract][Full Text] [Related]
10. B-vitamins and prevention of dementia.
Clarke R
Proc Nutr Soc; 2008 Feb; 67(1):75-81. PubMed ID: 18234134
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.
Heinz J; Kropf S; Luley C; Dierkes J
Am J Kidney Dis; 2009 Sep; 54(3):478-89. PubMed ID: 19359080
[TBL] [Abstract][Full Text] [Related]
12. [Group B vitamins as new variables related to the cardiovascular risk].
Granieri M; Bellisarii FI; De Caterina R
Ital Heart J Suppl; 2005 Jan; 6(1):1-16. PubMed ID: 15776726
[TBL] [Abstract][Full Text] [Related]
13. Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease.
Bleie Ø; Semb AG; Grundt H; Nordrehaug JE; Vollset SE; Ueland PM; Nilsen DW; Bakken AM; Refsum H; Nygård OK
J Intern Med; 2007 Aug; 262(2):244-53. PubMed ID: 17645592
[TBL] [Abstract][Full Text] [Related]
14. Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials.
Clarke R
Indian Heart J; 2000; 52(7 Suppl):S59-64. PubMed ID: 11339443
[TBL] [Abstract][Full Text] [Related]
15. Folic acid and vitamin B12 are more effective than vitamin B6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease.
Lee BJ; Huang MC; Chung LJ; Cheng CH; Lin KL; Su KH; Huang YC
Eur J Clin Nutr; 2004 Mar; 58(3):481-7. PubMed ID: 14985687
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine, B-vitamin supplementation, and stroke prevention: from observational to interventional trials.
Schwammenthal Y; Tanne D
Lancet Neurol; 2004 Aug; 3(8):493-5. PubMed ID: 15261610
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine-lowering trials for prevention of heart disease and stroke.
Clarke R
Semin Vasc Med; 2005 May; 5(2):215-22. PubMed ID: 16047274
[TBL] [Abstract][Full Text] [Related]
18. Why do homocysteine-lowering B vitamin and antioxidant E vitamin supplementations appear to be ineffective in the prevention of cardiovascular diseases?
Debreceni B; Debreceni L
Cardiovasc Ther; 2012 Aug; 30(4):227-33. PubMed ID: 21884001
[TBL] [Abstract][Full Text] [Related]
19. Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease.
Quinlivan EP; McPartlin J; McNulty H; Ward M; Strain JJ; Weir DG; Scott JM
Lancet; 2002 Jan; 359(9302):227-8. PubMed ID: 11812560
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial.
Saposnik G; Ray JG; Sheridan P; McQueen M; Lonn E;
Stroke; 2009 Apr; 40(4):1365-72. PubMed ID: 19228852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
